Tony is a former managing editor of BRW, Shares, Personal Investor, Asset and CFO magazines. He writes a weekly column for BRW and The Australian Financial Review, specialising in small listed companies,IPOs, entrepreneurship and innovation.
REVA Medical is working hard to stem the damage of a market backlash due to pilot clinical trial delays.
Comments